Advances in Precision and Personalized Medicine: March 14-15, 2019

** Deadline for applications for this workshop was January 30, 2019 **


This workshop will be held at SAS Hall on the campus of NC State University.


This workshop seeks to bring together experts in industry, academia, and regulatory affairs to discuss current advances and future goals in the field of precision medicine. In alignment with SAMSI’s year-long Program on Statistical, Mathematical, and Computational Methods for Precision Medicine (PMED), our speakers will range in topics from hospital care and workflow, pharmaceutical development, observational and real-world evidence, and regulatory developments.

The conference will feature world-leading presenters from industry, regulatory, and academia. Our speakers will cover a range of healthcare industries including hospitals, home care, insurance, Big Pharma, CROs, biotech, and mobile health.

The workshop will feature two round-table discussions:
1. Lessons and Challenges in Observational Health Data: A round-table debate on the work generated by the Observed Medical Outcomes Partnership (OMOP) and the Observational Health Data Sciences and Informatics program (OHDSI). The panel will be led by Rosa Gini (Agenzia regionale di sanità della Toscana, Florence, Italy), Miguel Hernan (Harvard), David Madigan (Columbia University), and Marc Suchard (UCLA).

2. Regulatory Advancements in the FDA: A panel discussion about recent developments in the FDA’s Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER). The panel will be led by Telba Irony (FDA CBER).

The workshop will also feature a presentation speed-session for researchers to introduce their work.
NOTE: Speaking slots for BOTH traditional and speed presentations are still available. For those who would like to actively participate in this workshop, please contact Glen Wright Colopy at

Confirmed speakers for this event include:

Schedule and Supporting Media

Printed Schedule
Poster Titles

** NOTE: Plenary Panels are confirmed. Invited Sessions may be subject to slight changes. **

Thursday, March 14, 2019
Auditorium Room 2203, SAS Hall, N.C. State University, Raleigh, N.C.

Time Description Speaker Slides
8:00-8:30am Registration and Poster Setup
Morning Session A
8:30-8:45am Introduction and Opening Remarks David Banks, SAMSI/Duke University
8:45-10:00am Session 1: Advances in Biopharmaceuticals Sophie Guo, Deep6 AI
Boris Hayete, GNS Healthcare
Jessilyn Dunn, Duke University
Xiling Shen, Duke University
Herb Weisberg, Causalytics, LLC
10:00-10:10am BREAK
10:10-10:55am Session 1: Advances in Biopharmaceuticals (continued) Lauren Drinkard, Lumeris
Jeff Painter, JiveCast
Warren Kibbe, Duke University
10:55-11:10am Discussion
11:10-11:30am BREAK
11:30am-12:30pm Plenary Panel: Lessons and Challenges in Observational Health Data Panelists
Moderator: Demissie Alemayheu, Columbia University
Rosa Gini, Agenzia Regionale di Sanità della Toscana
Miguel Hernan, Harvard University
David Madigan, Columbia University
Marc Suchard, UCLA
12:30-1:30pm LUNCH (on own)
1:30-2:30pm Session 2: Personalization in Hospital Care Madalina Fiterau, UMass Amherst
Alistair Johnson, MIT
Jeffery Fuller, UNC Health
Benjamin Villard, Oxford and University of Nagoya
2:30-2:50pm BREAK
2:50-4:00pm Session 3: Medical Device Analytics Brian K. Walsh, Liberty University
Christoper McCann, Current Health
Paolo Piraino, Bayer AG
Rebecca Krouse, Rho
4:00-5:00pm Session 4: Early Career Researcher/Poster Presentation Speed Session
Title: GBM Tumor Growth Trends from MRI Image Analysis Ramana Pidaparti, University of Georgia
Title: Receptor Conformational Heterogeneity Induced by different Beta-Adrenergic Receptor Blockers Bill Tian, Duke University
Title: Early Biomarker Signature Discovery by Analysing Exosome Profiles in Body Fluids Paritra Mandal, Clemson University
Title: Treatment Effect Inference using $2^k$ Factorial Designs with Longitudinal Potential Outcomes and Nonignorable Missing Hai-Yan Yu, Penn State University
Title: Integrative Analysis of Irregularly Measured Biomarkers of Mixed Types in Electronic Health Records Jitong Lou, UNC-Chapel Hill
Title: Using Wearables and Big Data to Prevent Diabetes Emilia Grzesiak, Duke University
Title: Improving Inference of Bayesian Network Structures in Experiments with Complex Designs Sara Mohammad Taheri, Northeastern University
Title: Sparse Learning for Image-on-Scalar Regression with Application to Imaging Genetics Studies Xinyi Li, SAMSI
Title: Learning Equations from Noisy Biological Data John Nardini, SAMSI
Title: A Method to Discover the Reliability of Claims Made in a Meta-Analysis Stan Young, CG Stat
Title: Lessons Learned in Application of Machine Learning in Industry Hoa Le, PAREXEL Int’l/UNC-Charlotte
Title: Using Latent Class Analysis to Identify Data Quality Issues in Patient Preference Studies Jessie Sutphin, RTI
Title: Sequence Analysis and Visualization of Cardio Vascular Events Deteced by Devices in Heart Failure Population Mercedeh Ghadessi, Bayer Pharmaceuticals
Title: Data & Analytics at Blue Cross Julie Fazio, Blue Cross, Blue shield-NC
Title: Combating Data Source Diversity and Complexity with Expanded Skills and Teamwork Derek Lawrence, Rho, Inc.
Heather Kopetskie, Rho, Inc.
5:00-7:00pm Poster Session and Social

Friday, March 15, 2019
Auditorium Room 2203, SAS Hall, N.C. State University, Raleigh, N.C.

Time Description Speaker Slides
8:00-8:30am Registration
8:30-9:30am Session 5: Advances in Industry Russell Reeve, IQVIA
Richard Zink, TARGET PharmaSolutions
Ilya Lipkovich, Eli Lilly, IQVIA
9:30-10:30am Session 6: Advances in Industry Glen Wright Colopy, Current Health and Oxford University
Jason Burke, UNC Healthcare
West Paul, WakeMed
10:30-11:00am BREAK
11:00-11:30am Session 7: Patient Preference Studies: Advancements in Industry Rachel DiSantostefano, Johnson & Johnson
Carol Mansfield, RTI
11:30am-12:30pm Plenary Panel: Regulatory Advancements in the FDA Panelists
Moderator: Lisa Lavange, University of North Carolina at Chapel Hill
Telba Irony, FDA CBER
Estelle Russek-Cohen, FDA CBER
John Scott, FDA CBER
Martin Ho, FDA CBER
12:30-1:00pm Closing Remarks, Lunch (on own) and Shuttle to RDU
1:00pm  → Lunch (on own) and Shuttle to RDU Airport

Questions: email